553 related articles for article (PubMed ID: 19726976)
1. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.
Mondello S; Linnet A; Buki A; Robicsek S; Gabrielli A; Tepas J; Papa L; Brophy GM; Tortella F; Hayes RL; Wang KK
Neurosurgery; 2012 Mar; 70(3):666-75. PubMed ID: 21937927
[TBL] [Abstract][Full Text] [Related]
3. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids.
Brophy GM; Mondello S; Papa L; Robicsek SA; Gabrielli A; Tepas J; Buki A; Robertson C; Tortella FC; Hayes RL; Wang KK
J Neurotrauma; 2011 Jun; 28(6):861-70. PubMed ID: 21309726
[TBL] [Abstract][Full Text] [Related]
4. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.
Papa L; Lewis LM; Silvestri S; Falk JL; Giordano P; Brophy GM; Demery JA; Liu MC; Mo J; Akinyi L; Mondello S; Schmid K; Robertson CS; Tortella FC; Hayes RL; Wang KK
J Trauma Acute Care Surg; 2012 May; 72(5):1335-44. PubMed ID: 22673263
[TBL] [Abstract][Full Text] [Related]
6. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
[TBL] [Abstract][Full Text] [Related]
7. Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury.
Papa L; Mittal MK; Ramirez J; Silvestri S; Giordano P; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano D; Zonfrillo MR
J Neurotrauma; 2017 Jul; 34(13):2132-2140. PubMed ID: 28158951
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury.
Stukas S; Gill J; Cooper J; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Dhall S; Mac-Thiong JM; Wilson JR; Bailey C; Christie S; Dvorak MF; Wellington C; Kwon BK
J Neurotrauma; 2021 Aug; 38(15):2055-2064. PubMed ID: 33504255
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning.
Pang L; Wu Y; Dong N; Xu DH; Wang DW; Wang ZH; Li XL; Bian M; Zhao HJ; Liu XL; Zhang N
Clin Biochem; 2014 Jan; 47(1-2):72-6. PubMed ID: 24080464
[TBL] [Abstract][Full Text] [Related]
10. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
[TBL] [Abstract][Full Text] [Related]
11. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
12. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
Svingos AM; Robicsek SA; Hayes RL; Wang KK; Robertson CS; Brophy GM; Papa L; Gabrielli A; Hannay HJ; Bauer RM; Heaton SC
Neurocrit Care; 2022 Aug; 37(1):172-183. PubMed ID: 35229233
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
14. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
15. Temporal Profile of Microtubule-Associated Protein 2: A Novel Indicator of Diffuse Brain Injury Severity and Early Mortality after Brain Trauma.
Papa L; Robicsek SA; Brophy GM; Wang KKW; Hannay HJ; Heaton S; Schmalfuss I; Gabrielli A; Hayes RL; Robertson CS
J Neurotrauma; 2018 Jan; 35(1):32-40. PubMed ID: 28895474
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
Liu MC; Akinyi L; Scharf D; Mo J; Larner SF; Muller U; Oli MW; Zheng W; Kobeissy F; Papa L; Lu XC; Dave JR; Tortella FC; Hayes RL; Wang KK
Eur J Neurosci; 2010 Feb; 31(4):722-32. PubMed ID: 20384815
[TBL] [Abstract][Full Text] [Related]
17. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.
Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC
JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834
[TBL] [Abstract][Full Text] [Related]
18. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.
Czeiter E; Mondello S; Kovacs N; Sandor J; Gabrielli A; Schmid K; Tortella F; Wang KK; Hayes RL; Barzo P; Ezer E; Doczi T; Buki A
J Neurotrauma; 2012 Jun; 29(9):1770-8. PubMed ID: 22435839
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure.
Li Y; Wang Z; Zhang B; Zhe X; Wang M; Bai J; Lin T; Zhang S
Epilepsy Res; 2013 Feb; 103(2-3):205-10. PubMed ID: 22920679
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.
Papa L; Robertson CS; Wang KK; Brophy GM; Hannay HJ; Heaton S; Schmalfuss I; Gabrielli A; Hayes RL; Robicsek SA
Neurocrit Care; 2015 Feb; 22(1):52-64. PubMed ID: 25052159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
